This Year in Medicine 2022: The Top HCPLive Stories of the Year

The most-read article on HCPLive this year was a summary of research into the benefit of real-time continuous glucose monitoring (CGM) on HbA1c reduction.

Is that surprising? Maybe a little disappointing? What about an article on omega-3 fatty acids for atrial fibrillation (AFib) risk reduction? A video interview on heart failure guidelines? These are hardly the outstanding headlines of 2022, yet they are among our most popular posts in these last 12 months.

We tend to believe the exceptional, the odd, or the exceptionally odd are what get the most attention in the news. In reality, the most popular stories have a streak of commonality: what affects the most will be read about the most. Think about those above stories; few chronic diseases are as prevalent and burdensome in the US than diabetes and cardiovascular disease.

Now think about the intent of those articles: updates on disease monitoring, risk reduction, guidelines and strategies. Few things better encapsulate the interests of our modern health care work force than desires to better manage, mitigate and prepare for preventable disease. This all tracks with what our audience most enjoyed from us this year.

This month, we want to share the ways how these commonly desired developments led to exceptional results in medicine through 2022.

Welcome back to This Year In Medicine, HCPLive’s annual recap series that reflects on the greatest stories, trends, issues and solutions in each specialty of our coverage. Every Monday, Wednesday and Friday of December, our team will be sharing stories and expert-driven content that speaks to the major development of health care; from RSV to colon cancer screening, from patient-reported outcomes to blindness-fighting drugs.

We’ll additionally be sharing materials from our sister publications in the greater HCPLive Network, highlighting the diversity of our coverage and the growing interplay of specialty care teams:

• NeurologyLive
• Contagion
• CGTLive
• Contemporary Pediatrics
• Contemporary OB/GYN

You can follow along the recap on Facebook, Twitter and LinkedIn, using the hashtag #ThisYearInMedicine, and each new entry will be shared on the HCPLive homepage as well as through our daily newsletter.

We hope you enjoy reflecting on the common stories that came to mean much more for medicine in 2022. For now, check out our 10 most read stories of the year:

• Real-Time Continuous Glucose Monitoring Linked to Greater Reduction in HbA1c
• Fish Oil Supplement Intake Influences Long-Term Atrial Fibrillation Risk
• Placebo Recipients in COVID-19 Vaccine Trials Often Report Adverse Events
• FDA Approves First Ever Rapid-Acting Treatment for Major Depressive Disorder
• Phase 1/2 Trial Reports Positive Initial Clinical Data of VRDN-001 in Thyroid Eye Disease
• Nihar Desai, MD, MPH: Improving PCSK9 Inhibitor Use, Guiding Heart Failure Care & ACC 2022 Headlines
• Comorbid Psychiatric Conditions Common for Adults With ADHD
• Glycemic Variability, High Glucose Increase Mortality Risk in Patients with Type 2 Diabetes
• The Promising Future of Vitiligo Treatment
• Bentracimab Reverses Antiplatelet Bleeding Effect of Ticagrelor in Phase 2b Trial